Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Superhemophobic Surfaces Could Enhance Implant Biocompatibility

By HospiMedica International staff writers
Posted on 01 Feb 2017
A new study describes how a specially grown titanium surface that is extremely repellent to blood could lower the risk of medical implant rejection.

Researchers at Colorado State University first analyzed variations of titanium surfaces, including different textures and chemistries, comparing them to define variations in platelet adhesion and activation. More...
They found that only superhemophobic surfaces with a robust Cassie–Baxter state displayed significantly low platelet adhesion and activation. In this state, liquid does not completely wet the surface texture; instead, pockets of air remain trapped underneath the liquid droplet, introducing a composite liquid–air–solid interface.

The researchers achieved the Cassie–Baxter state in titanium surfaces by combining a surface chemistry with low solid surface energy and an appropriate texture created via fluorinated nanotubes. The result was a metastable Cassie–Baxter state that greatly reduced the solid–liquid interfacial area. In fact, the researchers found that the surface was so repellent that blood is deceived into accepting there is almost no foreign material present. The study was published on December 21, 2016, in Advanced Healthcare Materials.

“A material phobic to blood might seem counterintuitive, as often biomedical scientists use materials with affinity to blood to make them biologically compatible,” said senior author professor of mechanical engineering and biomedical engineering Arun Kota, PhD. “What we are doing is the exact opposite. We are taking a material that blood hates to come in contact with, in order to make it compatible with blood.”

“Over time, stents can form clots, obstructions, and lead to heart attacks or embolisms. The reason blood clots is because it finds cells in the blood to go to and attach,” said corresponding author Ketul Popat, PhD. “Normally, blood flows in vessels. If we can design materials where blood barely contacts the surface, there is virtually no chance of clotting, which is a coordinated set of events. Here, we're targeting the prevention of the first set of events.”


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
New
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.